Denisa Wagner, Ph.D.
Dr. Denisa Wager is a professor of medicine at Harvard Medical School, a senior investigator in the Program in Cellular and Molecular Medicine, and a member of the Division of Hematology/Oncology at Boston Children's Hospital.
Dr. Wagner is a key opinion leader in the field of NETs with #XXX publications in this space. She brings deep understanding of vascular biology, adhesion molecules and inflammatory pathways to Neutrolis and is a co-inventor on core aspects of Neutrolis’s proprietary technology.
Her research efforts have uncovered foundational aspects of how pathogenic NETs influence both acute and chronic disorders in humans. These disorders include (thrombosis, atherosclerosis, reperfusion injury, wound healing, cancer associated thrombosis, stroke and ALI.